Altered placental expression of small humanin-like peptides in gestational diabetes mellitus

Sude  Dagli; Merve Ece  Oyur; Bedircan  Turan; Aysegul  Turkkol; Umut Kerem Kolac

doi:10.48101/ujms.v131.14142

Sude Dagli Faculty of Medicine, Aydin Adnan Menderes University, Aydin, Türkiye https://orcid.org/0009-0005-7058-7470
Merve Ece Oyur Department of Medical Biology, Faculty of Medicine, Aydin Adnan Menderes University, Aydin, Türkiye https://orcid.org/0009-0005-0654-4548
Bedircan Turan Department of Medical Biology, Faculty of Medicine, Aydin Adnan Menderes University, Aydin, Türkiye https://orcid.org/0009-0008-0221-1238
Aysegul Turkkol Department of Biophysics, Faculty of Medicine, Aydin Adnan Menderes University, Aydin, Türkiye https://orcid.org/0000-0003-1369-7241
Umut Kerem Kolac Department of Medical Biology, Faculty of Medicine, Aydin Adnan Menderes University, Aydin, Türkiye https://orcid.org/0000-0003-0266-9069

DOI: https://doi.org/10.48101/ujms.v131.14142

Keywords: Gestational diabetes mellitus, placenta, small humanin-like peptides, insulin resistance

Abstract

Background: Gestational diabetes mellitus (GDM) is characterized by maternal insulin resistance and hyperglycemia and has been associated with placental mitochondrial alterations. Small humanin-like peptides (SHLP1–6), encoded within the mitochondrial 16S rRNA region, have been described as mitochondria-derived peptides (MDPs) with reported cytoprotective and metabolic effects in experimental settings. However, their expression in placental tissues from GDM pregnancies has not been previously investigated.

Methods: Placental tissues were obtained from women with GDM and normoglycemic controls following cesarean delivery. Maternal fasting glucose, fasting insulin, glycated hemoglobin A1c (HbA1c), and the homeostatic model assessment for insulin resistance (HOMA-IR) were recorded. Total RNA was isolated from placental samples, and the mRNA expression levels of SHLP1–6 were quantified using quantitative real-time polymerase chain reaction (PCR). In addition, Humanin and SHLP2 peptide levels were assessed at the protein level. Group comparisons and correlation analyses were performed to evaluate associations between placental SHLP expression and maternal metabolic parameters within each group.

Results: Placental expression levels of all six SHLP transcripts were significantly reduced in the GDM group compared with controls. Lower placental SHLP expression was significantly associated with higher HOMA-IR and HbA1c values. In addition, reduced SHLP transcript levels were associated with increased neonatal birth weight. Consistently, Humanin and SHLP2 levels were significantly reduced in both serum and placental samples in the GDM group.

Conclusions: This study demonstrates that placental mRNA levels of SHLPs are reduced in pregnancies complicated by GDM and are associated with maternal metabolic status. The integration of transcriptional findings with targeted peptide measurements supports the notion that altered placental SHLP expression is linked to metabolic disturbances in GDM and warrants further investigation into the role of MDPs in placental adaptation during diabetic pregnancy.

Downloads

Download data is not yet available.

References

1.
Kolac UK, Eken MK, Ünübol M, Yalcin GD, Yalcin A. The effect of gestational diabetes on the expression of mitochondrial fusion proteins in placental tissue. Placenta. 2021;115:106–14. doi: 10.1016/j.placenta.2021.09.015

2.
Lappas M. Activation of inflammasomes in adipose tissue of women with gestational diabetes. Mol Cell Endocrinol. 2014;382:74–83. doi: 10.1016/j.mce.2013.09.011

3.
Nguyen-Ngo C, Jayabalan N, Salomon C, Lappas M. Molecular pathways disrupted by gestational diabetes mellitus. J Mol Endocrinol. 2019;63:R51–72. doi: 10.1530/JME-18-0274

4.
Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin Obstet Gynecol. 2007;50:938–48. doi: 10.1097/GRF.0b013e31815a5494

5.
Kolac UK, Donmez Yalcin G, Yalcin A. Chemical inhibition of mitochondrial fission improves insulin signaling and subdues hyperglycemia induced stress in placental trophoblast cells. Mol Biol Rep. 2023;50:493–506. doi: 10.1007/s11033-022-07959-0

6.
Lopez-Tello J, Pérez-García V, Khaira J, Kusinski LC, Cooper WN, Andreani A, et al. Fetal and trophoblast PI3K p110α have distinct roles in regulating resource supply to the growing fetus in mice. Elife. 2019;8:e45282. doi: 10.7554/eLife.45282

7.
Sandovici I, Hoelle K, Angiolini E, Constância M. Placental adaptations to the maternal–fetal environment: implications for fetal growth and developmental programming. Reprod Biomed Online. 2012;25:68–89. doi: 10.1016/j.rbmo.2012.03.017

8.
Desforges M, Sibley CP. Placental nutrient supply and fetal growth. Int J Dev Biol. 2010;54:377–90. doi: 10.1387/ijdb.082765md

9.
Burton G, Yung H, Murray A. Mitochondrial–endoplasmic reticulum interactions in the trophoblast: stress and senescence. Placenta. 2017;52:146–55. doi: 10.1016/j.placenta.2016.04.001

10.
Kolac UK. Inhibition of mitochondrial fission and protein kinase R improves progesterone in placental stress. J Mol Endocrinol. 2023;71:e230059. doi: 10.1530/JME-23-0059

11.
Martinez F, Olvera-Sanchez S, Esparza-Perusquia M, Gomez-Chang E, Flores-Herrera O. Multiple functions of syncytiotrophoblast mitochondria. Steroids. 2015;103:11–22. doi: 10.1016/j.steroids.2015.09.006

12.
McElwain C, McCarthy CM. Investigating mitochondrial dysfunction in gestational diabetes mellitus and elucidating if BMI is a causative mediator. Eur J Obstet Gynecol Reprod Biol. 2020;251:60–5. doi: 10.1016/j.ejogrb.2020.04.037

13.
Cobb LJ, Lee C, Xiao J, Yen K, Wong RG, Nakamura HK, et al. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging. 2016;8:796. doi: 10.18632/aging.100943

14.
Popov L-D. Mitochondrial peptides – appropriate options for therapeutic exploitation. Cell Tissue Res. 2019;377:161–5. doi: 10.1007/s00441-019-03049-z

15.
Merry TL, Chan A, Woodhead JS, Reynolds JC, Kumagai H, Kim S-J, et al. Mitochondrial-derived peptides in energy metabolism. Am J Physiol Endocrinol Metab. 2020;319:E659–66. doi: 10.1152/ajpendo.00249.2020

16.
Nashine S, Cohen P, Chwa M, Lu S, Nesburn AB, Kuppermann BD, et al. Humanin G (HNG) protects age-related macular degeneration (AMD) transmitochondrial ARPE-19 cybrids from mitochondrial and cellular damage. Cell Death Dis. 2017;8:e2951. doi: 10.1038/cddis.2017.348

17.
Gong Z, Tasset I, Diaz A, Anguiano J, Tas E, Cui L, et al. Humanin is an endogenous activator of chaperone-mediated autophagy. J Cell Biol. 2018;217:635–47. doi: 10.1083/jcb.201606095

18.
Minasyan L, Sreekumar PG, Hinton DR, Kannan R. Protective mechanisms of the mitochondrial-derived peptide humanin in oxidative and endoplasmic reticulum stress in RPE cells. Oxid Med Cell Longev. 2017;2017:1675230. doi: 10.1155/2017/1675230

19.
Thamarai Kannan H, Issac PK, Dey N, Guru A, Arockiaraj J. A review on mitochondrial derived peptide humanin and small humanin-like peptides and their therapeutic strategies. Int J Pept Res Ther. 2023;29:86. doi: 10.1007/s10989-023-10558-7

20.
Ryu J-H, Mangal U, Kim J-H, Yang DJ, Lee K-J, Choi Y-H, et al. SHLP2 restores pre-osteoblastic cells against oxidative stress-induced inflammaging. Sci Rep. 2025;16:938. doi: 10.1038/s41598-025-30415-5

21.
Nashine S, Cohen P, Nesburn AB, Kuppermann BD, Kenney MC. Characterizing the protective effects of SHLP2, a mitochondrial-derived peptide, in macular degeneration. Sci Rep. 2018;8:15175. doi: 10.1038/s41598-018-33290-5

22.
Mehta HH, Xiao J, Ramirez R, Miller B, Kim S-J, Cohen P, et al. Metabolomic profile of diet-induced obesity mice in response to humanin and small humanin-like peptide 2 treatment. Metabolomics. 2019;15:88. doi: 10.1007/s11306-019-1549-7

23.
Ruiz D, Santibañez M, Lavín BA, Berja A, Montalban C, Vazquez LA. Evolution of mitochondrially derived peptides humanin and motsc, and changes in insulin sensitivity during early gestation in women with and without gestational diabetes. J Clin Med. 2022;11:3003. doi: 10.3390/jcm11113003

24.
Voros C, Stavros S, Sapantzoglou I, Mavrogianni D, Daskalaki MA, Theodora M, et al. The role of placental mitochondrial dysfunction in adverse perinatal outcomes: a systematic review. J Clin Med. 2025;14:3838. doi: 10.3390/jcm14113838

25.
Marzioni D, Piani F, Di Simone N, Giannubilo SR, Ciavattini A, Tossetta G. Importance of STAT3 signaling in preeclampsia. Int J Mol Med. 2025;55:58. doi: 10.3892/ijmm.2025.5499

26.
Jahan F, Vasam G, Green AE, Bainbridge SA, Menzies KJ. Placental mitochondrial function and dysfunction in preeclampsia. Int J Mol Sci. 2023;24:4177. doi: 10.3390/ijms24044177

27.
Biri A, Onan A, Devrim E, Babacan F, Kavutcu M, Durak I. Oxidant status in maternal and cord plasma and placental tissue in gestational diabetes. Placenta. 2006;27:327–32. doi: 10.1016/j.placenta.2005.01.002

28.
Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol. 2019;11:45.

29.
Toledano JM, Puche-Juarez M, Galvez-Navas JM, Moreno-Fernandez J, Diaz-Castro J, Ochoa JJ. Pregnancy disorders: a potential role for mitochondrial altered homeostasis. Antioxidants. 2024;13:979. doi: 10.3390/antiox13080979

30.
Holland O, Nitert MD, Gallo LA, Vejzovic M, Fisher JJ, Perkins AV. Placental mitochondrial function and structure in gestational disorders. Placenta. 2017;54:2–9. doi: 10.1016/j.placenta.2016.12.012

31.
Kim SJ, Xiao J, Wan J, Cohen P, Yen K. Mitochondrially derived peptides as novel regulators of metabolism. J Physiol. 2017;595:6613–21. doi: 10.1113/JP274472

32.
Muzumdar RH, Huffman DM, Atzmon G, Buettner C, Cobb LJ, Fishman S, et al. Humanin: a novel central regulator of peripheral insulin action. PLoS One. 2009;4:e6334. doi: 10.1371/journal.pone.0006334

33.
Lee C, Zeng J, Drew BG, Sallam T, Martin-Montalvo A, Wan J, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21: 443–54. doi: 10.1016/j.cmet.2015.02.009

34.
Alis R, Lucia A, Blesa JR, Sanchis-Gomar F. The role of mitochondrial derived peptides (MDPs) in metabolism. J Cell Physiol. 2015;230:2903–4. doi: 10.1002/jcp.25023

35.
Ramanjaneya M, Bettahi I, Jerobin J, Chandra P, Abi Khalil C, Skarulis M, et al. Mitochondrial-derived peptides are down regulated in diabetes subjects. Front Endocrinol. 2019;10:331. doi: 10.3389/fendo.2019.00331

36.
Rochette L, Meloux A, Zeller M, Cottin Y, Vergely C. Role of humanin, a mitochondrial-derived peptide, in cardiovascular disorders. Arch Cardiovasc Dis. 2020;113:564–71. doi: 10.1016/j.acvd.2020.03.020

37.
Kose C, Korpe B, Yakut Yucel K, Arat O, Bucak M, Engin Ustun Y. A new antioxidant marker in cord blood of fetuses with late fetal growth restriction: humanin. Fetal Pediatr Pathol. 2023;42:775–84. doi: 10.1080/15513815.2023.2229432

38.
Firouzi F, Ramezani Tehrani F, Shaharki H, Mousavi M, Moradi N, Saei Ghare Naz M. First trimester hematological indices in gestational diabetes mellitus: a meta-analysis. J Endocr Soc. 2025;9:bvaf043. doi: 10.1210/jendso/bvaf043

39.
Wolf M, Sauk J, Shah A, Smirnakis KV, Jimenez-Kimble R, Ecker JL, et al. Inflammation and glucose intolerance. A prospective study of gestational diabetes mellitus. Clin Diabetol. 2004;5:85–94.